Hypohidrotic ectodermal dysplasia (EDA) has been localised to the ql2-q13
linkage analysis using closely linked flanking markers can clarify the carrier status for many females at risk for the disorder, knowledge of the origin of the mutation in instances of possible de novo mutation is critical for accurate genetic counselling of families. Two methods have been used to confirm de novo mutation in families with EDA and to trace their origin. Direct detection of three de novo molecular deletions, one arising during oogenesis and the other two during spermatogenesis, was achieved by Southern analyses using cosmids isolated from the EDA region as probes. Seven de novo mutations arising during spermatogenesis, and two possible de novo mutations during oogenesis, were identified by an analysis of the cosegregation of the disorder with polymorphic markers closely linked to and flanking the EDA locus. The confirmation and analysis of the origin of the 10 de novo mutations greatly assisted genetic counselling in these families. The apparent 3-5:1 excess of male to female origin of mutation in families studied with unidentified types of mutation is similar to other studies of X linked disorders, and suggests that the majority of these mutations may involve single base pair substitutions.
(J Med Genet 1994;31:287-292) Hypohidrotic ectodermal dysplasia (EDA), a disorder involving abnormal morphogenesis of teeth, hair, and eccrine sweat glands, has been localised to the q12-qI3.1 region of the X chromosome by genetic and physical mapping methods.'-5 Linkage analysis using closely linked flanking markers, in combination with physical examination, can modify the carrier risk for many females at risk for EDA.26 Although fully penetrant in males, clear physical manifestations of the disorder are present in only about two thirds of carriers, and reliance on more subtle subclinical signs, such as sweat pore counts, can be misleading.78 The identification of de novo mutations and knowledge of their origin is critical for proper genetic counselling in many families. For example, clinically unaffected mothers of sporadic cases may have inherited the gene from their mother, be a non-manifesting carrier owing to a new germline mutation in one of the maternal grandparents, or be a non-carrier with mutation arising during oogenesis. We sought to confirm apparent de novo mutations and detect their origin in families with EDA by both direct and indirect methods of molecular analysis. The first method used screened for detectable rearrangements of genomic DNA by Southern analysis with cosmids, previously localised to the EDA region, as probes.' The second method analysed the segregation of the disorder in families with polymorphic marker loci closely flanking the EDA locus. Analysis of the segregation of alleles at the polymorphic loci flanking the EDA locus showed the mother (II-2) to be informative for the flanking loci DXS339 and DXS441. The haplotype of flanking markers segregating with the disorder is that of the maternal grandfather (fig 2A) . Therefore, the mutation probably missing multiple fragments on hybridisation of cosmid ICRFc1O4C11.138 to DNA digested separately with several restriction enzymes ( fig  5) . He was not deleted for any of the cosmids used as probes from contig groups A-C, nor for the YAC end clone LX5c4. Analysis of polymorphic loci flanking the EDA locus showed that the proband had inherited his allele at the DXS339 locus from the maternal grandfather. Since the proband's mother is clearly affected, and no recombinants have been observed to date between the DSX339 and EDA loci, the mutation probably arose during spermatogenesis in the maternal grandfather. Neither he nor the maternal grandmother showed evidence of the deletion upon
IDENTIFICATION OF DE NOVO MUTATIONS BY HAPLOTYPE ANALYSIS
Nine families with unidentified mutations had a pedigree structure potentially informative for analysis of possible de novo mutations with relevant samples available (fig 6) . Informative flanking markers were present in all nine families. In seven of the families studied, the haplotype segregating with the disorder was inherited from the maternal grandfather, and in two cases from the maternal grandmother.
In the seven families where the mutation was present on the maternal grandfather's haplotype, the mutation had to have arisen either during spermatogenesis or postzygotically in the mother, since the disorder shows complete penetrance in males. In either case, the carrier risk of the maternal grandmother and great aunts of the proband is eliminated. 
